Plus Therapeutics
PSTV
PSTV was delisted on the 31st of July, 2026.
5 hedge funds and large institutions have $457K invested in Plus Therapeutics in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 5 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.02% less ownership
Funds ownership: 0.04% → 0.02% (-0.02%)
44% less funds holding
Funds holding: 9 → 5 (-4)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
64% less capital invested
Capital invested by funds: $1.28M → $457K (-$822K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$18.4K |
| 2 |
Bank of New York Mellon
New York
|
+$4.61K |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
+$2.31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$562K |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$50K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$37K |
| 4 |
EGM
Engineers Gate Manager
New York
|
-$28K |
| 5 |
Renaissance Technologies
New York
|
-$9.22K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
BlackRock
New York
| $228K | – | – | – |
|
|
2
Renaissance Technologies
New York
| $152K | -$9.22K | -12 | -5% |
|
|
3
Bank of New York Mellon
New York
| $58K | +$4.61K | +6 | +8% |
|
|
4
Acadian Asset Management
Boston,
Massachusetts
| $17K | +$18.4K | +24 | New |
|
|
5
Victory Capital Management
San Antonio,
Texas
| $2K | +$2.31K | +3 | New |
|
|
FDCDDQ
6
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $2 | – | – | – |
|
|
FP
7
Financial Perspectives
Minneapolis,
Minnesota
| $2 | – | – | – |
|
|
SM
8
Sabby Management
Miami Beach,
Florida
| – | -$562K | -624 | Closed |
|
|
OAM
9
Oxford Asset Management
Oxford,
United Kingdom
| – | -$50K | -55 | Closed |
|
|
10
Citadel Advisors
Miami,
Florida
| – | -$37K | -42 | Closed |
|
|
EGM
11
Engineers Gate Manager
New York
| – | -$28K | -31 | Closed |
|
12
Wells Fargo
San Francisco,
California
| – | -$2.31K | -3 | Closed |
|
PSTV Hedge Fund Activity: Q1 2020 in Review
5 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q1 2020, worth a combined $457K — down 64% from $1.28M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PSTV and 2 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Acadian Asset Management, opening a new position worth an estimated $18.4K. The largest seller was Sabby Management, exiting entirely with an estimated $562K sold.
- 5 institutional investors held Plus Therapeutics (PSTV) as of Q1 2020, down from 9 in Q4 2019.
- Funds reported $457K of Plus Therapeutics stock for Q1 2020, down 64% quarter-over-quarter.
- 2 funds opened new Plus Therapeutics positions in Q1 2020 and 5 closed out, a net change of -3 holders.
- The largest Plus Therapeutics buyer in Q1 2020 was Acadian Asset Management, an estimated $18.4K added.
- The largest Plus Therapeutics seller in Q1 2020 was Sabby Management, an estimated $562K sold.
Based on aggregated 13F filings for Q1 2020.